Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 850
Last updated 2025-06-29
Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
Conditions
Sponsors & Collaborators
-
Exact Sciences Corporation
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-20
- Primary Completion
- 2025-03-31
- Completion
- 2025-05-29
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
NCT03563651 ·Status: COMPLETED
-
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
NCT03741166 ·Status: COMPLETED
-
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
NCT03476122 ·Status: UNKNOWN
-
Stool Sample Collection Study
NCT06294873 ·Status: RECRUITING
-
CRC Detection Reliable Assessment With Blood
NCT05551052 ·Status: ACTIVE_NOT_RECRUITING
-
Plasma-based Colorectal Cancer Screening Research & Development
NCT04027790 ·Status: COMPLETED
-
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
NCT04473625 ·Status: COMPLETED
-
Identification of New Diagnostic Protein Markers for Colorectal Cancer
NCT04394572 ·Status: COMPLETED
-
Validation of a Molecular Signature for Early Detection of Colorectal Cancer
NCT06738511 ·Status: COMPLETED ·Phase: NA
-
Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
NCT00897403 ·Status: COMPLETED
-
Relapse Markers for Colorectal Cancer
NCT04920955 ·Status: COMPLETED
-
Screening Tests in Detecting Colorectal Cancer
NCT00025025 ·Status: COMPLETED
-
Metabolomics-Based Detection of Colorectal Cancer
NCT00507598 ·Status: COMPLETED
-
A Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03676075 ·Status: UNKNOWN
-
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
NCT06889844 ·Status: RECRUITING
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT00899626 ·Status: RECRUITING
-
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT07046585 ·Status: RECRUITING
-
Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection
NCT03146520 ·Status: COMPLETED
-
Molecular Profiling of Colorectal Cancer
NCT04863768 ·Status: UNKNOWN
-
An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
NCT07033156 ·Status: RECRUITING
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia
NCT04427527 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360 ·Status: UNKNOWN
-
Outreach and Choice in Colorectal Cancer Screening
NCT04940442 ·Status: UNKNOWN ·Phase: NA